Skip to main content

GOLDMAN SACHS GROUP INC

Position in CLYM — Climb Bio, Inc.

CIK 886982 NEW YORK, NY

Position in CLYM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,085,319
+$58,026 QoQ
Shares Held
83,230
-44.5% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 109 holders
Holding Since
Sep 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CLYM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. CLYM ranks #253 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CLYM

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,085,319 83,230
2026-03-31 $1,027,293 149,970
2025-12-31 $899,532 224,883
2025-09-30 $148,166 73,715
2025-06-30 $249,626 201,312
2025-03-31 $147,304 120,742
2024-12-31 $225,547 125,304
2024-09-30 $300,544 59,046
2022-06-30 $491,631 162,792
2022-03-31 $1,385,079 165,087
2021-12-31 $1,716,726 164,123
2021-09-30 $2,983,816 165,952